Balaxi Pharmaceuticals Reports Nil Share Re-Lodgement Requests for Oct'26
Balaxi Pharmaceuticals Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 4:40 am
Balaxi Pharmaceuticals Reports Nil Share Re-Lodgement Requests for Oct'26 Balaxi Pharmaceuticals Limited submitted its Registrar and Share Transfer Agent report from Aarthi Consultants Private Limited for the period ended Oct'26. In compliance with the SEBI circular dated 30th Jan'26 regarding the re-lodgement of transfer requests for physical shares, the company confirmed that zero requests were received, processed, approved, or rejected during the month. Consequently, the average processing turnaround time for the period was not applicable.
Original exchange filing (PDF)
More announcements from Balaxi Pharmaceuticals Ltd
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation 路 16 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated November 12, 2026, titled "Balaxi Pharmaceuticals Limited Reports Strong Q2 FY27 Performance; Revenue Grows 45%, EBITDA Surges 338% and PAT Rises 450% YoY". 路 13 Nov 2026
- Balaxi Pharmaceuticals Limited has informed the Exchange regarding Progress of the Company's Pharmaceutical Formulation Plant at Jadcherla, Hyderabad. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about change in Management 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on November 12, 2026. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
- To consider and approve the Unaudited Standalone and Consolidated financial results of the Company for the second quarter and half year ended 30th September, 2026 of the Financial Year 2026-27, and other business matters. 路 12 Nov 2026
